The same day the tirzepatide decision was released, the FDA posted that it continues to actively monitor drug availability and is currently working to determine whether the demand or projected demand for each drug in shortage, including semaglutide, exceeds the available supply. An update in the back-and-forth between the FDA and compounder associations, which sued the FDA when they first lifted the shortage in October, is due later this week
The Metabolic Syndrome and Male Infertility
Identify the manufacturer of the medication
Its designed for: experienced gym users, intense cutting phases, athletes, and people already used to stimulants
Clinical studies are scarce, highlighting the need for further research to assess bone quality and long-term skeletal outcomes in individuals using GLP-1s
El metaanlisis de Desai et al., 2024 intent filtrar solo DEXA/MRI, pero aun as ms de 40 % de estudios tuvo algn riesgo de sesgo